Premium
Development of a three‐dimensional model for rapid evaluation of bone substitutes in vitro : Effect of the 45S5 bioglass
Author(s) -
Alno Nora,
Jegoux Franck,
PellenMussi Pascal,
TricotDoleux Sylvie,
Oudadesse Hassane,
Cathelineau Guy,
De Mello Gilbert
Publication year - 2010
Publication title -
journal of biomedical materials research part a
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.849
H-Index - 150
eISSN - 1552-4965
pISSN - 1549-3296
DOI - 10.1002/jbm.a.32818
Subject(s) - spheroid , materials science , cell culture , cell growth , biomedical engineering , viability assay , in vitro , microbiology and biotechnology , cytotoxicity , cell , biology , biochemistry , medicine , genetics
The evaluation of innovative bone substitutes requires the development of an optimal model close to physiological conditions. An interesting alternative is the use of an immortalized cell line to construct multicellular spheroids, that is, three‐dimensional (3D) cultures. In this study, a modified hanging drops method has resulted in the generation of spheroids with a well‐established human fetal osteoblasts line (hFOB 1.19), and tests have been focused on the effect of 45S5 bioglass ionic dissolution products in comparison with two‐dimensional (2D) cultures. Depending on cell culture type, quantitative analysis (cell proliferation, viability/cytotoxicity, and cellular cycle) and qualitative analysis (electron microscopy and genes expression) showed a differential effect. Cell proliferation was enhanced in 2D‐conditioned cultures in accordance with literature data, but decreased in 3D cultures submitted to the same conditions, without change of gene expression patterns. The decrease of cell proliferation, observed in conditioned spheroids, appears to be in agreement with clinical observations showing the insufficiency of commercially available bioglasses for bone repairing within nonbearing sites, such as periodontal defects or small bone filling, in general. Therefore, we suggest that this model could be adapted to the screening of innovative bioactive materials by laboratory techniques already available and extended monitoring of their bioactivity. © 2010 Wiley Periodicals, Inc. J Biomed Mater Res Part A, 2010.